Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IMP3 pseudogene 1 (IMP3P1) is a processed pseudogene in humans that shares sequence similarity with the protein-coding gene IMP3 (U3 small nucleolar ribonucleoprotein IMP3). IMP3 is involved in ribosomal RNA processing and nucleolar structure, but IMP3P1 itself does not encode a functional protein and has no known biological or clinical function[2][4][7]. Pseudogenes like IMP3P1 may have regulatory RNA roles in rare cases, but there is no evidence for IMP3P1 being a therapeutic target or disease biomarker. Clarification: If your intent is to refer to the functional protein-coding gene (U3 small nucleolar ribonucleoprotein IMP3), you should use "IMP3" rather than "IMP3P1." Drug targeting, biological function, and disease relevance pertain to the protein-coding IMP3 gene, not the pseudogene IMP3P1[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IMP3 pseudogene 1 (IMP3P1).